Could shedding assets spell a breakthrough for troubled GE?

Feb 25, 2019
General Electric today announced the sale of its biopharmaceutical business for more than $21 billion dollars. The buyer is Danaher Corporation, which happens to have been previously run by GE chief executive Larry Kulp, who served as chief executive at Danaher between 2001 and 2015. The move is part of an ongoing restructuring aimed at […]

$5/month special ending soon!

Don’t wait: there’s less than 24 hours left to get (almost) any Marketplace thank-you gift.